May 8, 2026 - 02:27

Absci has provided updates on its clinical programs and released its financial results for the first quarter of 2026. The company announced it has successfully dosed all four planned healthy volunteer cohorts in the single ascending dose (SAD) portion of its ongoing ABS-201 HEADLINE trial. The drug, being developed for androgenetic alopecia (AGA), or pattern hair loss, was reported to be well-tolerated with favorable emerging safety data.
Preliminary pharmacokinetic modeling from the HEADLINE trial supports the targeted dosing interval for ABS-201. The company has also initiated dosing for the first multiple ascending dose (MAD) cohort in participants with AGA.
Beyond ABS-201, Absci is expanding its prolactin program by adding ABS-202 to its internal pipeline. The company is headquartered in Vancouver, Washington, and also has operations in New York. The first quarter financial report covers the period ending March 31, 2026.
August 5, 2026 - 23:52
ABA Centers of America Continues to Shed JobsABA Centers of America has continued to reduce its workforce over the summer months, following an initial round of layoffs announced in June. The company, which provides applied behavior analysis...
August 5, 2026 - 07:49
Fountain Square businesses plead for support as $14M project enters final phaseBusiness owners in Indianapolis`s Fountain Square are asking customers to stick with them as a long-running infrastructure overhaul finally nears its end. The $14 million drainage and streetscape...
August 4, 2026 - 20:29
The List: Clark County banksThe financial landscape in Clark County continues to shift as new data reveals which banks hold the most money from local customers. The latest figures, based on total deposits held within the...
August 4, 2026 - 02:16
Ukraine uses business principles to maximize Russia’s casualties and economic costs, potentially crushing its will to keep fighting, RAND saysUkraine has quietly adopted a corporate-style approach to its war effort, setting key performance indicators for its military just as a company would for its employees or branch offices. According...